stub A Breakthrough in Terpene Analysis Reveals Differential Abundance of Terpene Compounds Across Six Cannabis Strains - MyCannabis.com
Connect with us

Health

A Breakthrough in Terpene Analysis Reveals Differential Abundance of Terpene Compounds Across Six Cannabis Strains

mm
Updated on

Cannabis, revered for both recreational and medicinal use, holds a treasure trove of compounds contributing to its distinctive properties. Among these, terpenes and terpenoids play a pivotal role in shaping the aroma and flavor profile of different cannabis strains. In a recent study by the University of British Columbia titled “Comprehensive Profiling of Terpenes and Terpenoids in Different Cannabis Strains Using GC × GC-TOFMS,” researchers employed advanced technology to analyze terpenes and terpenoids in different cannabis strains.

Key Findings

Advanced Analytical Technique:

  • GC × GC-TOFMS demonstrated superior separation and identification capabilities, overcoming co-elution challenges in conventional GC analyses.

Rich Chemical Profile:

  • Analysis of six cannabis strains revealed a diverse array of 146 terpenes and terpenoids.

Identification Success:

  • 23 compounds were definitively identified using a standard mixture, while 51 received putative names.

Enhanced Separation with GC × GC:

  • Application of GC × GC facilitated enhanced separation in the second dimension, revealing 16 unique terpenes and terpenoids in cannabis strains and four from a standard mixture.

Discovery of New Terpenoids:

  • Four previously undiscovered terpenoids were identified for the first time in cannabis.

Chemical Diversity Among Strains:

  • Variability observed in the number and relative abundance of compounds within each terpene and terpenoid category across the six cannabis strains underscores chemical diversity.

Methodology

The study scrutinized terpenes and terpenoids in dried flowers from six cannabis strains using GC × GC-TOFMS. The enhanced separation technique in the second dimension revealed 16 previously co-eluted compounds, shedding light on the intricate chemical makeup of cannabis.

Findings

This study underscores the effectiveness of GC × GC-TOFMS in providing superior separation and identification capabilities, addressing the co-elution challenge often encountered in conventional GC analyses. A comprehensive analysis of six cannabis strains revealed the presence of 146 terpenes and terpenoids. Among these, 23 compounds were definitively identified through a standard mixture, while 51 received putative names. Notably, GC × GC facilitated enhanced separation in the second dimension, unveiling 16 terpenes and terpenoids unique to cannabis strains, along with four from a standard mixture. The groundbreaking identification of four previously undiscovered terpenoids adds novel dimensions to cannabis research. The variability in the number and relative abundance of compounds within each terpene and terpenoid category across the six cannabis strains highlights the chemical diversity inherent in different strains. This study lays the groundwork for future extensions to explore additional cannabis strains, aiming to uncover a more exhaustive list of terpenes and terpenoids. Furthermore, the potential therapeutic effects of the identified compounds present exciting avenues for future research and exploration within the realm of cannabis science.

Future Directions

The study paves the way for further exploration, encouraging the extension of these findings to other cannabis strains. Additionally, researchers propose evaluating the potential therapeutic effects of the identified compounds, opening doors to new dimensions in cannabis research.

The collaboration between technology, represented by GC × GC-TOFMS, and the cannabis industry has unraveled the complex tapestry of terpenes and terpenoids. As we unveil the aromatic secrets hidden within different strains, the potential applications in product development and medicinal research promise a future where cannabis can be appreciated not only for its recreational aspects but also for its nuanced therapeutic contributions.

 

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.


Warning: Trying to access array offset on value of type bool in /home/customer/www/mycannabis.com/public_html/wp-content/themes/zox-news-child/functions.php on line 830

Warning: Attempt to read property "taxonomy" on null in /home/customer/www/mycannabis.com/public_html/wp-content/themes/zox-news-child/functions.php on line 830